Real-World Evidence on Mobile App-Supported Diabetes Management in Insulin-Treated Patients.

ABSTRACT:

Background

Digital health interventions, such as mobile diabetes apps, are aimed at supporting glycemic control. Real-world data (RWD) provide valuable insights into their long-term effectiveness beyond the controlled conditions of randomized trials.

Objective

This study evaluates the effectiveness of the mobile diabetes app ESYSTA in improving glycemic control using real-world evidence.

Methods

A retrospective analysis of 475 users was conducted to assess HbA1c changes after 6 months of usage and also long-term usage (12 and 15 months). A linear mixed model was used to adjust for confounding factors.

Results

After 6 months, ESYSTA users achieved a significant HbA1c reduction of -0.59 (-0.70; -0.48) percentage points compared to baseline, which was maintained f

SUBMITTER: Roth L 

PROVIDER: S-EPMC12767227 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature